285124
Local health department efficiency: A data envelopment analysis
METHODS: This study uses data envelopment analysis (DEA) to create an estimate frontier of LHD efficiency. DEA is frequently employed in determining ideal operation in other health care organizations, but is still a novel tool in public health. Inputs for the model consist of cost data from the 1997, 2005, and 2010 waves of the National Association of County and City Health Officials (NACCHO) Profile of Local Health Departments and data on public health services availability from the 1998, 2006, and 2012 waves of the National Longitudinal Survey of Public Health Systems (NLSPHS). The NLSPHS follows a nationally-representative cohort of local public health systems over time (n=397), profiling the availability of 20 core public health services within their jurisdictions, the organizations that deliver each, and the perceived effectiveness of services.
RESULTS: The analysis will show to what extent LHD efficiency, how many public health services they are providing with the smallest amount of inputs (costs), varies across our sample. In addition, we will capture the changes in efficiency at 3 time points (1998, 2006, and 2012).
Public health or related public policy
Public health or related research
Learning Objectives:
Explain the use of data envelopment analysis in looking at local health departments.
Identify the optimal level of local health department efficiency in terms of cost and public health services provided.
Compare local health department efficiency levels.
Keywords: Economic Analysis, Public Health Research
Qualified on the content I am responsible for because: I am a second year DrPH student in Health Services Management with a strong interest in public health system structure and organization. I also work as a graduate research assistant in the National Coordinating Centers for Public Health Practice-based Research Networks and Public Health Systems and Services Research.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.